Test Price
2,800 AEDโ Home Collection Available
NPHS1 Gene Nephrotic Syndrome Type 2 Genetic Test in UAE | 2800 AED
Executive Summary & Core Metrics
Clinical Excellence & UAE-Compliant Genetic Diagnostics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified NGS processing.
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain and VIP Mobile Phlebotomy.
- Clinical Guidance: Telephonic Post-Test Clinical Interpretation by expert genetic counsellors.
- Insurance Direct Billing: Verify coverage via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The NPHS1 Gene Nephrotic Syndrome Type 2 Genetic Test uses Next-Generation Sequencing (NGS) to detect pathogenic variants in the NPHS1 gene, confirming congenital nephrotic syndrome of the Finnish type. This definitive molecular diagnosis guides nephrologists and geneticists in early management, family planning, and prognostic counselling.
| Feature | Our NGS Test | Alternative (Sanger) |
|---|---|---|
| Precision | Full gene sequencing, CNV detection | Limited to known hotspots |
| Method | NGS (Next-Generation Sequencing) | Sanger Sequencing |
| Turnaround Time | 3โ4 Weeks | 4โ6 Weeks (partial analysis) |
| Regulatory Compliance | DHA/MOHAP, UAE PDPL, Federal Law No. 2 of 2019 | Variable |
Physician Insight & Safety Protocols
โA confirmed pathogenic NPHS1 mutation is not just a laboratory finding โ it demands compassionate integration with clinical nephrology, family history, and long-term care planning. As a Consultant Medical Genetics, I recommend this test as part of a comprehensive diagnostic strategy that includes renal function assessment and genetic counselling for at-risk family members.โ
โ Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Advisory
Do Not Discontinue Prescribed Therapy
โ Do not stop any prescribed medication โ particularly diuretics, ACE inhibitors, or immunosuppressants โ without explicit advice from your treating nephrologist. Sudden cessation may lead to acute decompensation.
Exclusion Criteria & Emergency Red Flags
Exclusion Criteria
- Exclusion: Inability to provide informed consent; minors without parental/guardian authorization in compliance with Federal Decree-Law No. 4 of 2016 on Medical Liability.
Emergency Red Flags
- Rapid onset of generalized edema (anasarca)
- Severe hypertension or hypertensive urgency
- Oliguria or acute kidney injury
- Febrile illness with flank pain โ seek immediate medical attention.
Patient FAQ & Clinical Guidance
1. What does the NPHS1 genetic test detect and why is it recommended?
This test uses next-generation sequencing to identify disease-causing mutations in the NPHS1 gene, providing a definitive diagnosis of congenital nephrotic syndrome type 2. Early detection enables timely intervention, including nutritional support, diuretic management, and genetic counselling for the family.
2. How is the sample collected and what are the preโtest requirements?
A peripheral blood sample (5โ10 mL) is collected by our VIP mobile phlebotomy team. No special preparation is required, but a mandatory pre-test genetic counselling session is scheduled to document family history and discuss implications. Home collection is available daily from 8 AM to 11 PM.
3. What turnaround time and support can I expect after the test?
Results are available within 3 to 4 weeks from sample receipt. A telephonic post-test consultation with a Consultant Medical Genetics is included to interpret findings, discuss family planning, and coordinate nephrology follow-up.
UAE Regulatory & Data Privacy Adherence
Compliance Framework
All genetic data are processed and stored in accordance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Reports are encrypted, access-limited, and shared only with the ordering physician. Patient consent is obtained per the medical liability requirements of Federal Decree-Law No. 4 of 2016.
Clinical & Logistical Metadata
| Test Name | NPHS1 Gene Nephrotic Syndrome Type 2 Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3โ4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (EDTA) or Extracted DNA |
| Methodology Used | Next-Generation Sequencing (NGS) โ Full gene coverage including CNV detection |
| ICD-10-CM Code | N04.9 |
| LOINC Code | 81430-7 |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE โ DNA Labs UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians